Deepa Bhojwani

9.8k citations

111 papers · 3.5k indexed · h-index 31

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 0.5%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 37
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 11
Public Health, Environmental and Occupational Health 81
- Acute Lymphoblastic Leukemia research 81

Co-authors: Ching‐Hon Pui Jun J. Yang Elizabeth A. Raetz William L. Carroll Mary V. Relling Sima Jeha John T. Sandlund Jeffrey E. Rubnitz
Journals: Blood (29 papers)Journal of Clinical Oncology (9 papers)Pediatric Blood & Cancer (9 papers)Leukemia (5 papers)Cancer (4 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Deepa Bhojwani

102 papers receiving 3.4k citations

Peers

Countries citing papers authored by Deepa Bhojwani

Since Specialization

Citations

This map shows the geographic impact of Deepa Bhojwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Bhojwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Bhojwani more than expected).

Fields of papers citing papers by Deepa Bhojwani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Bhojwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Bhojwani. The network helps show where Deepa Bhojwani may publish in the future.

Co-authors

The 25 scholars most cited alongside Deepa Bhojwani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deepa Bhojwani Line = papers co-authored together Deepa Bhojwani links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes Modern Pathology ·Travis K. Smith, Jeffrey Jean, Stephen Phan, Alexandra E. Kovach, Karin Miller, Jennifer Han, Katherine Ma, Cindy Fong, Andrew Doan, Deepa Bhojwani, Gordana Raca	2025	0
2	Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL) Transplantation and Cellular Therapy ·Armin Ghobadi, Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel, Dholaria Bhagirathbhai, Rawan Faramand, Ryan J. Mattison, Michael P. Rettig, Kenneth Jacobs, Ouiam Bakkacha, John Muth, Angela Pannunzio, Angela Pannunzio, Brett Ramsey, Eileen McNulty, Matthew Cooper, Jan Davidson‐Moncada, John F. DiPersio	2024	1
3	IKZF1 ^PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B‐lymphoblastic leukemia Pediatric Blood & Cancer ·Alexandra E. Kovach, Maximilian D. Wengyn, My H. Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani	2024	0
4	A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia Blood ·Amanda M. Li, Catherine Aftandilian, Susan I. Colace, Sarah Fanizzi, Kelly Faulk, Erin Guest, Ammar Hayani, Richard Ho, Anjali Khanna, Kasey J. Leger, David McCall, Tamara P. Miller, Holly Pacenta, Troy C. Quigg, Jeremy D. Rubinstein, Deepa Bhojwani, Susan R. Rheingold, Maureen M. O’Brien, Karen R. Rabin	2024	0
5	Clinical Actionability of the NUDT15 4 (p.R139H) Allele and Its Association With Hispanic Ethnicity Clinical Pharmacology & Therapeutics* ·Maud Maillard, Jenny Q. Nguyen, Wenjian Yang, Keito Hoshitsuki, Mary V. Relling, Kelly E. Caudle, Kristine R. Crews, Sima Jeha, Hiroto Inaba, Ching‐Hon Pui, Smita Bhatia, Seth E. Karol, Federico Antillón‐Klussmann, Cyrine E. Haidar, Deepa Bhojwani, Jun J. Yang	2024	0
6	CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells Blood Cancer Discovery ·Samy Jambon, Jianping Sun, Shawn Barman, Sakunthala Muthugounder, Xue Rachel Bito, Armita Shadfar, Alexandra E. Kovach, Brent L. Wood, Varsha Thoppey Manoharan, A. Sorana Morrissy, Deepa Bhojwani, Alan S. Wayne, Michael A. Pulsipher, Yong‐Mi Kim, Shahab Asgharzadeh, Chintan Parekh, Babak Moghimi	2024	6
7	Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Cancers ·Anupam Verma, Yueh‐Yun Chi, Jemily Malvar, Adam J. Lamble, Sonali Chaudhury, Archana M. Agarwal, Hongtao Li, Gangning Liang, Roy Leong, Patrick A. Brown, Joel A. Kaplan, Eric S. Schafer, Tamra Slone, Melinda Pauly, Bill H. Chang, Elliot Stieglitz, Alan S. Wayne, Nobuko Hijiya, Deepa Bhojwani	2024	6
8	Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory Journal of Molecular Diagnostics ·Zunsong Hu, Alexandra E. Kovach, Venkata D. Yellapantula, Dejerianne Ostrow, Andrew Doan, Jianling Ji, Ryan J. Schmidt, Zhaohui Gu, Deepa Bhojwani, Gordana Raca	2023	7
9	Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure Transplantation and Cellular Therapy ·Elizabeth M. Holland, Bonnie Yates, Seth M. Steinberg, Constance M. Yuan, Hao‐Wei Wang, Colleen Annesley, Haneen Shalabi, David F. Stroncek, Terry J. Fry, Joerg Krueger, Elad Jacoby, Emily M. Hsieh, Deepa Bhojwani, Rebecca Gardner, Shannon L. Maude, Nirali N. Shah	2023	4
10	Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial Blood Advances ·G.A. Amos Burke, Luciana Vinti, Edita Kabíčková, Auke Beishuizen, Nurdan Taçyıldız, Anne Uyttebroeck, Hyoung Jin Kang, Flávio Augusto Vercillo Luisi, Véronique Minard‐Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin E. Norris, Mitchell S. Cairo	2022	6
11	Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium Pediatric Blood & Cancer ·Eric S. Schafer, Karen Chao, Alexandra M. Stevens, Eunji Jo, Susan G. Hilsenbeck, Nathan Gossai, Andrew Doan, Susan I. Colace, Terri Guinipero, Daniel Otterson, Joel A. Kaplan, Ashley Hinson, Lauren Pommert, Alan S. Wayne, Deepa Bhojwani, Michael J. Burke	2022	7
12	A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732 Blood ·Jennifer L. McNeer, Maureen M. O’Brien, Susan R. Rheingold, Meenakshi Devidas, Zhiguo Chen, Deepa Bhojwani, Anurag K. Agrawal, Brent Wood, Eugene Suh, Sarah Alexander, Tamara P. Miller, Olga Militano, Elizabeth A. Raetz, Mignon L. Loh	2021	8
13	A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies Cancer Genetics ·Matthew Hiemenz, Matthew J. Oberley, Andrew Doan, Le Aye, Jianling Ji, Ryan J. Schmidt, Jaclyn A. Biegel, Deepa Bhojwani, Gordana Raca	2021	7
14	ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia Clinical Cancer Research ·Heng Xu, Xujie Zhao, Deepa Bhojwani, E Shuyu, Charnise Goodings, Hui Zhang, Nita L. Seibel, Wentao Yang, Chunliang Li, William L. Carroll, William E. Evans, Jun J. Yang	2019	21
15	Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia Pediatric Blood & Cancer ·Matthew J. Oberley, Paul S. Gaynon, Deepa Bhojwani, Michael A. Pulsipher, Rebecca Gardner, Matthew Hiemenz, Jianling Ji, Jennifer Han, Maurice R.G. O’Gorman, Alan S. Wayne, Gordana Raca	2018	60
16	The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL Cancers ·Etai Adam, Hye Na Kim, Eun Ji Gang, Caitlin Schnair, Solomon Lee, Solah Lee, Sajad Khazal, Osanna Kosoyan, Marina Konopleva, Chintan Parekh, Deepa Bhojwani, Alan S. Wayne, Hisham Abdel‐Azim, Nora Heisterkamp, Yong‐Mi Kim	2017	13
17	Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia Journal of Clinical Oncology ·Deepa Bhojwani, Noah D. Sabin, Deqing Pei, Jun J. Yang, Raja B. Khan, John C. Panetta, Kevin R. Krull, Hiroto Inaba, Jeffrey E. Rubnitz, Monika L. Metzger, Scott C. Howard, Raul C. Ribeiro, Cheng Cheng, Wilburn E. Reddick, Sima Jeha, John T. Sandlund, William E. Evans, Ching‐Hon Pui, Mary V. Relling	2014	242
18	Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Journal of Clinical Oncology ·Kevin R. Krull, Deepa Bhojwani, Heather M. Conklin, Deqing Pei, Cheng Cheng, Wilburn E. Reddick, John T. Sandlund, Ching‐Hon Pui	2013	77
19	A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) Journal of Pediatric Hematology/Oncology ·Elizabeth A. Raetz, D. Morrison, Eleny Romanos‐Sirakis, Paul S. Gaynon, Richard Sposto, Deepa Bhojwani, Bruce Bostrom, Patrick A. Brown, Elena Eckroth, Jeannette Cassar, Jemily Malvar, Aby Buchbinder, William L. Carroll	2013	34
20	Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles Leukemia ·Michael Loudin, Jia‐Bin Wang, H-C Eastwood Leung, S. Gurusiddappa, Julia Meyer, Gregory Condos, D. Morrison, Anna Tsimelzon, Meenakshi Devidas, Nyla A. Heerema, Andrew J. Carroll, Sharon E. Plon, Stephen P. Hunger, Giuseppe Basso, Andrea Pession, Deepa Bhojwani, William L. Carroll, Karen R. Rabin	2011	30

About Deepa Bhojwani

Deepa Bhojwani is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Genetics and Oncology, having authored 111 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (81 papers), Childhood Cancer Survivors' Quality of Life (31 papers), Acute Myeloid Leukemia Research (23 papers), CAR-T cell therapy research (20 papers), Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer therapeutics and mechanisms (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (1.1k citations), Public Health, Environmental and Occupational Health (2.2k citations), Pediatrics, Perinatology and Child Health (1.2k citations), Genetics (388 citations) and Oncology (957 citations). Deepa Bhojwani has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Ching‐Hon Pui, Jun J. Yang, Elizabeth A. Raetz, William L. Carroll, Mary V. Relling, Sima Jeha, John T. Sandlund, Jeffrey E. Rubnitz, Deqing Pei and Scott C. Howard. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, Leukemia and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact